On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Trade Desk, Inc. TTD is an "expensive stock, but it is a good one." The company’s stock gained around 61% year-to-date.
When asked about Adient plc ADNT, he said, "I can’t recommend anything that’s even remotely near the blast zone that is autos right now."
Cramer said he has been shocked that Occidental Petroleum Corporation OXY hasn’t moved up more "since Warren Buffett continues to buy it, but oil has been a surprising loser here." He added, "I would suggest that you take a hard look at buying the stock of Coterra Energy Inc. CTRA."
When asked about Marvell Technology, Inc. MRVL, he said, "I think that Matt Murphy is doing a terrific job…but I think that the better buy right now may actually be Broadcom Inc. AVGO."
Cramer said he doesn’t like AT&T Inc. T.
"I think it’s a terrific situation," Cramer said about Northrop Grumman Corporation NOC. "I think you’ve got a fine one in Northrop Grumman, buy more."
Don’t forget to check out our premarket coverage here
The "Mad Money" host said Edwards Lifesciences Corporation EW reported a "terrible" quarter. "They must do better than that," he added.
When asked about Lucid Group, Inc. LCID, Cramer said he is not recommending any stocks that are losing lots of money.
Cramer said Emerson Electric Co. EMR remains a "core holding" for his charitable trust.
Price Action: Shares of Emerson rose 0.7% to close at $89.61, while Lucid fell 1.7% to $4.05 on Wednesday. Edwards Lifesciences rose 0.2% to settle at $63.83, while Northrop Grumman fell 0.7% to close at $468.26 during Wednesday’s session. Shares of AT&T gained 1.2% to close at $15.58, while Marvell gained 1% to $47.70 on Wednesday. Broadcom shares rose 1.4% to $852.94, while Coterra gained 0.2% to settle at $27.55. Shares of Occidental Petroleum fell 0.7%, while Adient and Trade Desk lost 0.3% each on Wednesday.
Read This Next: Cramer Says This Stock Up 51% Year-To-Date Is A 'Buy Here'
Photo: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.